News - Appointments

Cynthia Butitta joins board of Autolus

Cynthia Butitta

Cynthia Butitta, the former chief operating officer of Kite Pharma (now Gilead Sciences Inc), has joined Autolus Ltd as a member of its board of directors.

Country: United Kingdom

Read more

Genomics England appoints John Mattick as first CEO

John Mattick

Genomics England has appointed the genomics pioneer John Mattick as its first chief executive to lead the organisation’s work in sequencing 100,000 genomes from patients in the UK National He

Country: United Kingdom

Read more

Hans van Eenennaam to lead Aduro Biotech Europe

Hans van Eenennaam

Hans van Eenennaam, one of the scientists who discovered the pembrolizumab checkpoint antibody, has been promoted to the role of executive vice president for antibody research and site head of Adur

Country: Netherlands

Read more

Claes Buxfeldt becomes director at NDA

Claes Buxfeldt

The NDA regulatory consultancy has appointed Claes Buxfeldt, a former executive at AstraZeneca Plc, as HTA director and a member of its advisory board.

Country: Sweden

Read more

Ipsen appoints Ivana Magovčević-Liebisch as CBO

Ivana Magovčević-Liebisch

Ipsen SA has appointed Ivana Magovčević-Liebisch as its chief business officer to help oversee the company’s external innovation and partnering strategy.

Country: France

Read more

Domainex appoints Bodo Spori as head of business development

Bodo Spori

Domainex Ltd has hired Bodo Spori from Cyprotex to become its head of business development for Europe, managing the company’s drug discovery services business.

Country: United Kingdom

Read more

Affimed appoints Leila Alland as CMO

Leila Alland

Affimed NV has appointed Leila Alland as chief medical officer to manage the clinical strategy and execution of the company’s NK and T cell therapy programmes for cancer.

Country: Germany

Read more

Richard Beckman becomes CMO at ReNeuron

Richard Beckman

ReNeuron Group Plc has appointed Richard Beckman as its chief medical officer, based in Boston, US where he will lead the cell therapy company’s clinical and medical affairs teams.

Country: United Kingdom

Read more

Modus Therapeutics appoints John Öhd as CMO

John Öhd

Modus Therapeutics AB has appointed John Öhd as chief medical officer to manage its portfolio which focuse on sickle cell disease.

Country: Sweden

Read more

Kai Pinkernell joins executive board of Medigene

Kai Pinkernell

Kai Pinkernell has joined the executive management board of Medigene AG as chief development officer, in addition to his role as chief medical officer.

Country: Germany

Read more